Manufacturer record
Onus Life Sciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Onus Life Sciences (Andhra Pradesh) were declared Not of Standard Quality in February 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: OFD.275, Ofsin-D (Ofloxacin Suspension), 60 ml (exp Aug 2024). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Ofloxacin. Listed in the February 2023 alert.
Records by type
2 records linked to Onus Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofsin-D (Ofloxacin Suspension), 60 ml | Batch OFD.275Mfg Sep 2022 · Exp Aug 2024 | Assay of OfloxacinAssay | CDL KolkataCDSCO lab | Feb 2023 |
| COOL PLUS Syrup (Paracetamol, Phenylephrine Hcl, Chloropheniramine Maleate, Sodium Citrate & Menthol Syrup), 60 ml | Batch OCP.260Mfg Apr 2022 · Exp Mar 2024 | Assay of Phenylephrine Hydrochloride & Sodium CitrateAssay | CDL KolkataCDSCO lab | Feb 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.